People who have uncontrolled seizures are at heightened risk for SUDEP

NewsGuard 100/100 Score

One in 26 Americans will develop epilepsy over the course of a lifetime leading to nearly three million Americans now living with epilepsy. For nearly one-third of them, their seizures are uncontrolled by medicine and other common forms of treatment. People who have uncontrolled seizures are at heightened risk for Sudden Unexpected Death in Epilepsy (SUDEP), which takes more lives annually in the United States than fires and sudden infant death syndrome (SIDS) combined.

To address SUDEP, epilepsy experts, people with epilepsy, bereaved families and advocacy organizations have come together for the Partners Against Mortality in Epilepsy (PAME) Conference -- a four-day educational event devoted predominately to SUDEP. This meeting aims to foster knowledge, heighten awareness and to hasten action around epilepsy mortality. Top researchers from around the world will be presenting the latest discoveries and findings on SUDEP and discussing the latest developments in devices and treatments to prevent epilepsy mortality.

According to the National Institutes of Health, SUDEP is the most common epilepsy-related cause of death. Yet, for many families facing epilepsy, information regarding SUDEP is not provided by their doctors, creating a communication gap that impacts a patient's ability to take steps to minimize their risk.

"There is a growing need for communications between researchers, clinicians, families and the public in order to identify approaches which may be useful to all people involved in caring for someone with epilepsy," said Elson So, president, American Epilepsy Society. "The goal of this conference is to build cross-fertilization of information so that clinical interactions can be better informed by patients and families and so that clinicians can better recognize risk factors and involve families in timely discussion of these risks."

Source:

National Institutes of Health

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis